Research & Literature

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.

Saliba AN, Harb AR, Taher AT

Journal of blood medicine 2015; (6()):197-209 doi:10.2147/JBM.S72463.

β-Thalassemia Intermedia Caused by Compound Heterozygosity for Hb Lepore-Hollandia and β-Thalassemia is Rare in the Indian Population.

Sreedharanunni S, Chhabra S, Hira JK, et al.

Hemoglobin 2015; (39(5)):362-5 doi:10.3109/03630269.2015.1064004.

Pregnancy outcomes among women with beta-thalassemia trait.

Charoenboon C, Jatavan P, Traisrisilp K, Tongsong T

Archives of gynecology and obstetrics 2016; (293(4)):771-4 doi:10.1007/s00404-015-3908-6.

Increasing prevalence of thalassemia in America: Implications for primary care.

Sayani FA, Kwiatkowski JL

Annals of medicine 2015; (47(7)):592-604 doi:10.3109/07853890.2015.1091942.

Hemoglobin F Only Syndrome at Birth: A Case of Maternal HbA2' Complicating the Diagnosis of β-Thalassemia.

Yee ME, Quarmyne MO, Segbefia C, et al.

Journal of pediatric hematology/oncology 2016; (38(1)):e32-4 doi:10.1097/MPH.0000000000000477.

Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.

Saliba AN, El Rassi F, Taher AT

Expert review of hematology 2016; (9(2)):151-68 doi:10.1586/17474086.2016.1126176.

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes.

Ricchi P, Marsella M

Drug design, development and therapy 2015; (9()):6475-82 doi:10.2147/DDDT.S40694.

Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions.

Chalmers AW, Shammo JM

Therapeutics and clinical risk management 2016; (12()):201-8 doi:10.2147/TCRM.S82449.

Hematological and biochemical status of Beta-thalassemia major patients in Bangladesh: A comparative analysis.

Karim MF, Ismail M, Hasan AM, Shekhar HU

International journal of hematology-oncology and stem cell research 2016; (10(1)):7-12.

Thalassemia, extramedullary hematopoiesis, and spinal cord compression: A case report.

Bukhari SS, Junaid M, Rashid MU

Surgical neurology international 2016; (7(Suppl 5)):S148-52 doi:10.4103/2152-7806.177891.

Current and future alternative therapies for beta-thalassemia major.

de Dreuzy E, Bhukhai K, Leboulch P, Payen E

Biomedical journal 2016; (39(1)):24-38.

Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients.

Russo V, Rago A, Papa AA, Nigro G

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2016; (21(4)):335-42 doi:10.1111/anec.12389.

Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran.

Seyedifar M, Dorkoosh FA, Hamidieh AA, et al.

International journal of hematology-oncology and stem cell research 2016; (10(4)):224-231.

Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.

Wahidiyat PA, Liauw F, Sekarsari D, et al.

Hematology (Amsterdam, Netherlands) 2017; (22(8)):501-507 doi:10.1080/10245332.2017.1292614.

Health-related Quality of Life and its Predictors Among Transfusion-dependent Thalassemia Patients.

Tuysuz G, Tayfun F

Journal of pediatric hematology/oncology 2017; (39(5)):332-336 doi:10.1097/MPH.0000000000000790.

Effect of breastfeeding versus infant formula on iron status of infants with beta thalassemia major.

El Safy UR, Fathy MM, Hassan TH, et al.

International breastfeeding journal 2016; (12()):18 doi:10.1186/s13006-017-0111-3.

Alpha thalassemia deletions found in suspected cases of beta thalassemia major in Pakistani population.

Shahid S, Nadeem M, Zahid D, et al.

Pakistan journal of medical sciences 2017; (33(2)):411-416 doi:10.12669/pjms.332.11834.

Advances in iron chelation therapy: transitioning to a new oral formulation.

Shah NR

Drugs in context 2017; (6()):212502 doi:10.7573/dic.212502.

The Effect of Partnership Care Model on Mental Health of Patients with Thalassemia Major.

Shamsi A, Amiri F, Ebadi A, Ghaderi M

Depression research and treatment 2017; (2017()):3685402 doi:10.1155/2017/3685402.

Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).

Maira D, Cassinerio E, Marcon A, et al.

Annals of hematology 2017; (96(11)):1931-1936 doi:10.1007/s00277-017-3120-9.

Is the Benefit-Risk Ratio for Patients with Transfusion-Dependent Thalassemia Treated by Unrelated Cord Blood Transplantation Favorable?

Jaing TH

International journal of molecular sciences 2017; (18(11)) doi:10.3390/ijms18112472.

Iron overload in thalassemia: different organs at different rates.

Taher AT, Saliba AN

Hematology. American Society of Hematology. Education Program 2017; (2017(1)):265-271 doi:10.1182/asheducation-2017.1.265.

Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.

Shenoy S, Walters MC, Ngwube A, et al.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018; (24(6)):1216-1222 doi:10.1016/j.bbmt.2018.01.023.

Clinical Classification, Screening and Diagnosis for Thalassemia.

Viprakasit V, Ekwattanakit S

Hematology/oncology clinics of North America 2018; (32(2)):193-211 doi:10.1016/j.hoc.2017.11.006.

Iron Chelation Therapy as a Modality of Management.

Aydinok Y

Hematology/oncology clinics of North America 2018; (32(2)):261-275 doi:10.1016/j.hoc.2017.12.002.

PREVALENCE AND RISK FACTORS FOR CARDIAC IRON OVERLOAD AND CARDIOVASCULAR COMPLICATIONS AMONG PATIENTS WITH THALASSEMIA IN NORTHERN THAILAND.

Tantiworawit A, Tapanya S, Phrommintikul A, et al.

The Southeast Asian journal of tropical medicine and public health 2016; (47(6)):1335-42.

The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review.

Ballas SK, Zeidan AM, Duong VH, et al.

American journal of hematology 2018; (93(7)):943-952 doi:10.1002/ajh.25103.

Transitioning Patients With Iron Overload From Exjade to Jadenu.

Tinsley SM, Hoehner-Cooper CM

Journal of infusion nursing : the official publication of the Infusion Nurses Society 2018; (41(3)):171-175 doi:10.1097/NAN.0000000000000278.

Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.

Karakas Z, Yilmaz Y, Bayramoglu Z, et al.

La Radiologia medica 2018; (123(8)):572-576 doi:10.1007/s11547-018-0889-0.

Genotype-phenotype correlation among beta-thalassemia and beta-thalassemia/HbE disease in Thai children: predictable clinical spectrum using genotypic analysis.

Traivaree C, Monsereenusorn C, Rujkijyanont P, et al.

Journal of blood medicine 2018; (9()):35-41 doi:10.2147/JBM.S159295.

Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.

Kuba A, Raida L

Mediators of inflammation 2018; (2018()):9451950 doi:10.1155/2018/9451950.

Clinical utility of endocrine markers predicting myocardial siderosis in transfusion dependent thalassemia major.

Ehsan L, Rashid M, Alvi N, et al.

Pediatric blood & cancer 2018; (65(10)):e27285 doi:10.1002/pbc.27285.

Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes.

Kattamis A, Aydinok Y, Taher A

European journal of haematology 2018; (101(3)):272-282 doi:10.1111/ejh.13111.

Hematopoietic stem cell transplantation for non-malignant hematological disorders.

Formánková R, Starý J

Vnitrni lekarstvi 2018; (64(5)):530-536.

Increased Prevalence of Thalassemia in Young People in Korea: Impact of Increasing Immigration.

Lee HJ, Shin KH, Kim HH, et al.

Annals of laboratory medicine 2019; (39(2)):133-140 doi:10.3343/alm.2019.39.2.133.

Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography.

Al-Khabori M, Daar S, Al-Busafi SA, et al.

Hematology (Amsterdam, Netherlands) 2019; (24(1)):183-188 doi:10.1080/10245332.2018.1540518.

Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia.

Romanello KS, Teixeira KKL, Silva JPMO, et al.

PloS one 2018; (13(12)):e0208316 doi:10.1371/journal.pone.0208316.

Blessing in disguise; a case of Hereditary Persistence of Fetal Hemoglobin.

Shaukat I, Pudal A, Yassin S, et al.

Journal of community hospital internal medicine perspectives 2018; (8(6)):380-381 doi:10.1080/20009666.2018.1536241.

Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.

Koohi F, Kazemi T, Miri-Moghaddam E

Annals of hematology 2019; (98(6)):1323-1331 doi:10.1007/s00277-019-03618-w.

N-terminal-pro-b-type natriuretic peptide levels and cardiac hemosiderosis in adolescent β-thalassemia major patients.

Kautsar A, Advani N, Andriastuti M

Annals of pediatric cardiology 2019; (12(1)):32-37 doi:10.4103/apc.APC_49_18.

Allogenic Hematopoietic Cell Transplantation in Thalassemia Major: A Single-center Retrospective Analysis From India.

Choudhary D, Doval D, Sharma SK, et al.

Journal of pediatric hematology/oncology 2019; (41(5)):e296-e301 doi:10.1097/MPH.0000000000001475.

G-CSF-Mobilized Blood and Bone Marrow Grafts as the Source of Stem Cells for HLA-Identical Sibling Transplantation in Patients with Thalassemia Major.

Li Q, Luo J, Zhang Z, et al.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019; (25(10)):2040-2044 doi:10.1016/j.bbmt.2019.06.009.

Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.

Bordbar M, Bozorgi H, Saki F, et al.

Journal of endocrinological investigation 2019; (42(12)):1467-1476 doi:10.1007/s40618-019-01072-z.

Molecular characteristics of thalassemia and hemoglobin variants in prenatal diagnosis program in northern Thailand.

Mankhemthong K, Phusua A, Suanta S, et al.

International journal of hematology 2019; (110(4)):474-481 doi:10.1007/s12185-019-02694-y.

Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major.

Pellegrino F, Zatelli MC, Bondanelli M, et al.

Endocrine 2019; (65(3)):469-482 doi:10.1007/s12020-019-02003-x.

A case of post-splenectomy transfusion-dependent homozygous beta-thalassemia major complicated with myocardial siderosis and osteoporosis and usage of iron-chelating therapy with deferiprone in pregnancy.

Ahmad MF, Zakaria NZ, Arsad N, et al.

Hormone molecular biology and clinical investigation 2019; (39(2)).

Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia.

Hamed EM, Meabed MH, Aly UF, Hussein RRS

Current drug targets 2019; (20(16)):1603-1623 doi:10.2174/1389450120666190726155733.

Beta Thalassemia Major with Gaucher's Disease: A Rare Entity.

Bai N, Nasir S, Ahmed J, et al.

Cureus 2019; (11(7)):e5179 doi:10.7759/cureus.5179.

Rare double heterozygosity for poly A(A〉 G) and CD17(A〉 T) of beta thalassemia intermedia in a Chinese family.

Xie J, Zhou Y, Xiao Q, et al.

Hematology reports 2019; (11(3)):7911 doi:10.4081/hr.2019.7911.

Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.

Heydarian S, Jafari R, Dailami KN, et al.

International ophthalmology 2020; (40(2)):511-527 doi:10.1007/s10792-019-01189-3.

The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia.

Chuansumrit A, Sirachainan N, Kitpoka P, et al.

Hemoglobin 2019; (43(4-5)):264-272 doi:10.1080/03630269.2019.1692863.

Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers.

Russo V, Melillo E, Papa AA, et al.

Cardiology research and practice 2019; (2019()):9319832 doi:10.1155/2019/9319832.

An Unusual Presentation of a Patient with Leg Ulcers: A Case Report.

Zafar S, Saleem K, Rashid A

Cureus 2019; (11(12)):e6293 doi:10.7759/cureus.6293.

[Clinical practice guidelines for beta-thalassemia].

Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association , Shang X, Wu X, et al.

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(3)):243-251 doi:10.3760/cma.j.issn.1003-9406.2020.03.004.

The mRNA-Binding Protein IGF2BP1 Restores Fetal Hemoglobin in Cultured Erythroid Cells from Patients with β-Hemoglobin Disorders.

Chambers CB, Gross J, Pratt K, et al.

Molecular therapy. Methods & clinical development 2020; (17()):429-440 doi:10.1016/j.omtm.2020.01.011.

Major Depression in Children with Transfusion-Dependent Thalassemia Is Strongly Associated with the Combined Effects of Blood Transfusion Rate, Iron Overload, and Increased Pro-inflammatory Cytokines.

Al-Hakeim HK, Najm AH, Al-Dujaili AH, Maes M

Neurotoxicity research 2020; (38(1)):228-241 doi:10.1007/s12640-020-00193-1.

Health-related quality of life among children with transfusion-dependent thalassemia: A cross-sectional study in Malaysia.

Shafie AA, Chhabra IK, Wong JHY, et al.

Health and quality of life outcomes 2020; (18(1)):141 doi:10.1186/s12955-020-01381-5.

The corrected QT interval prolongation in adolescents with cardiac iron overload β-thalassemia major.

Advani N, Advani N, Andriastuti M

The Turkish journal of pediatrics 2020; (62(2)):267-273.

Leukocyte telomere length in patients with transfusion-dependent thalassemia.

Nanthatanti N, Tantiworawit A, Piriyakhuntorn P, et al.

BMC medical genomics 2020; (13(1)):73 doi:10.1186/s12920-020-00734-9.

Socio-religious Prognosticators of Psychosocial Burden of Beta Thalassemia Major.

Ul Hassan Rashid MA, Abbasi SS, Manzoor MM

Journal of religion and health 2020; (59(6)):2866-2881 doi:10.1007/s10943-020-01069-6.

Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.

Kountouris P, Michailidou K, Christou S, et al.

Haematologica 2021; (106(9)):2458-2468 doi:10.3324/haematol.2020.260224.

Using LIBS as a diagnostic tool in pediatrics beta-thalassemia.

Alsharnoubi J, Nassef Y, Fahmy RF, Gamal M

Lasers in medical science 2021; (36(5)):957-963 doi:10.1007/s10103-020-03117-9.

Pituitary Iron Deposition and Endocrine Complications in Patients with β-Thalassemia: From Childhood to Adulthood.

Karadag SIK, Karakas Z, Yilmaz Y, et al.

Hemoglobin 2020; (44(5)):344-348 doi:10.1080/03630269.2020.1812636.

Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.

Rostami T, Monzavi SM, Poustchi H, et al.

International journal of hematology 2021; (113(1)):145-157 doi:10.1007/s12185-020-02998-4.

XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia.

Guillem F, Dussiot M, Colin E, et al.

Haematologica 2020; (105(9)):2240-2249 doi:10.3324/haematol.2018.210054.

Activin Receptor-Ligand Trap for the Treatment of β-thalassemia: A Serendipitous Discovery.

Brancaleoni V, Nava I, Delbini P, et al.

Mediterranean journal of hematology and infectious diseases 2020; (12(1)):e2020075 doi:10.4084/MJHID.2020.075.

Hematopoietic Stem Cell Transplantation in Thalassemia Patients: a Jordanian Single Centre Experience.

Mustafa M, Qatawneh M, Al Jazazi M, et al.

Materia socio-medica 2020; (32(4)):277-282 doi:10.5455/msm.2020.32.277-282.

The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.

Chaosuwannakit N, Makarawate P, Wanitpongpun C

Tomography (Ann Arbor, Mich.) 2021; (7(2)):130-138 doi:10.3390/tomography7020012.

Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.

Gamberini MR, Fortini M, Stievano A, et al.

Transfusion 2021; (61(6)):1729-1739 doi:10.1111/trf.16432.

Novel therapies in β-thalassaemia.

Grech L, Borg K, Borg J

British journal of clinical pharmacology 2022; (88(6)):2509-2524 doi:10.1111/bcp.14918.

Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major.

Nuzzi R, Geronazzo G, Tridico F, et al.

Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):2099-2109 doi:10.2147/OPTH.S300974.

Low back pain in beta thalassemia major revealing sacral extramedullay hematopoeisis: A case report.

Ahmad RW, Okar LA, Elhiday A, et al.

Clinical case reports 2021; (9(5)):e04258 doi:10.1002/ccr3.4258.

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.

Kansal AR, Reifsnider OS, Brand SB, et al.

Journal of market access & health policy 2021; (9(1)):1922028 doi:10.1080/20016689.2021.1922028.

β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies.

Barbarani G, Łabedz A, Ronchi AE

Frontiers in genome editing 2020; (2()):571239 doi:10.3389/fgeed.2020.571239.

Current status of beta-thalassemia and its treatment strategies.

Ali S, Mumtaz S, Shakir HA, et al.

Molecular genetics & genomic medicine 2021; (9(12)):e1788 doi:10.1002/mgg3.1788.

β-Thalassemia: evolving treatment options beyond transfusion and iron chelation.

Langer AL, Esrick EB

Hematology. American Society of Hematology. Education Program 2021; (2021(1)):600-606 doi:10.1182/hematology.2021000313.

Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia.

Locatelli F, Thompson AA, Kwiatkowski JL, et al.

The New England journal of medicine 2022; (386(5)):415-427 doi:10.1056/NEJMoa2113206.

Radiographic Features of the Maxillofacial Anomalies in Beta-Thalassemia Major: With New View.

Bayati S, Keikhaei B, Bahadoram M, et al.

World journal of plastic surgery 2021; (10(3)):78-83 doi:10.29252/wjps.10.3.78.

Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.

Lüftinger R, Zubarovskaya N, Galimard JE, et al.

Annals of hematology 2022; (101(3)):655-665 doi:10.1007/s00277-021-04732-4.

Alpha- and Beta-thalassemia: Rapid Evidence Review.

Baird DC, Batten SH, Sparks SK

American family physician 2022; (105(3)):272-280.

Transient Elastography of Liver and Serum Hyaluronic Acid Levels In Adult Transfusion Dependent Thalassemia Patients.

Yadav V, Margekar SL, Agrawal A, Prakash A

The Journal of the Association of Physicians of India 2022; (70(4)):11-12.

Prevalence and risk factors of fractures in transfusion dependent thalassemia - A Hong Kong Chinese population cohort.

Lee SLK, Wong RSM, Li CK, Leung WK

Endocrinology, diabetes & metabolism 2022; (5(4)):e340 doi:10.1002/edm2.340.

The Evaluation of Results of Twenty Common Equations for Differentiation of Beta Thalassemia Trait from Iron Deficiency Anemia: A Cross-Sectional Study.

Ebrahimpour Sadagheyani H, Sharafkhani R, Sakhaei S, et al.

Iranian journal of public health 2022; (51(4)):929-938 doi:10.18502/ijph.v51i4.9255.

Transient neonatal hemolytic anemia due to the novel gamma globin gene mutation HBG2:C.290T>C, p.Leu97Pro (hemoglobin Wareham).

Gorfinkel L, Wachter F, Luo HY, et al.

Pediatric blood & cancer 2023; (70(1)):e30067 doi:10.1002/pbc.30067.

Spectrum of hemoglobinopathies with hematological and biochemical profile: A five year experience from a tertiary care hospital.

Mansoor N, Meraj F, Shaikh A, Jabbar N

Pakistan journal of medical sciences 2022; (38(8)):2143-2149 doi:10.12669/pjms.38.8.5935.

Correlation of Transient Elastography With MRI T2* and Serum Ferritin Levels in Children With Transfusion-Dependent Thalassemia.

Parakh N, Chandra J

Indian pediatrics 2022; (59(12)):929-932.

Compound Heterogeneous Sickle Cell-B+ Thalassemia Incidentally Discovered Through Cytological Examination of a Fine-Needle Aspiration Specimen from an Aneurysmal Bone Cyst in a Young Child: A Case Report.

Meliti A, Muftah S, Saleh D, Habibullah N

Cureus 2023; (15(1)):e33594 doi:10.7759/cureus.33594.

Hematopoietic Stem Cell Transplantation in Thalassemia.

Algeri M, Lodi M, Locatelli F

Hematology/oncology clinics of North America 2023; (37(2)):413-432 doi:10.1016/j.hoc.2022.12.009.

Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials.

Segura EER, Ayoub PG, Hart KL, Kohn DB

Viruses 2023; (15(3)) doi:10.3390/v15030713.

Transition of Care for Patients with Thalassemia.

Chandra J, Sahi PK

Indian journal of pediatrics 2023; (90(12)):1227-1231 doi:10.1007/s12098-023-04595-9.

The role of extracellular vesicles on the occurrence of clinical complications in β-thalassemia.

Abdolalian M, Zarif MN, Javan M

Experimental hematology 2023; (127()):28-39 doi:10.1016/j.exphem.2023.08.009.

Correlation of Transient Elastography with Liver Iron Concentration and Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia Major from Oman.

Khan H, Panjwani V, Al Rahbi S, et al.

Mediterranean journal of hematology and infectious diseases 2023; (15(1)):e2023048 doi:10.4084/MJHID.2023.048.

Case Report: β-thalassemia major on the East African coast.

Macharia AW, Mochamah G, Makale J, et al.

Wellcome open research 2022; (7()):188 doi:10.12688/wellcomeopenres.17907.1.

Effects on hearing after long-term use of iron chelators in beta-thalassemia: Over twenty years of longitudinal follow-up.

Aldè M, Ambrosetti U, Giuditta M, et al.

Auris, nasus, larynx 2024; (51(2)):271-275 doi:10.1016/j.anl.2023.10.005.

MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.

El Osta M, Benoist JF, Naubourg P, et al.

Clinical chemistry and laboratory medicine 2024; (62(6)):1149-1157 doi:10.1515/cclm-2023-1250.

A Cross-Sectional, Multicentric, Disease-Specific, Health-Related Quality of Life Study in Greek Transfusion Dependent Thalassemia Patients.

Klonizakis P, Roy N, Papatsouma I, et al.

Healthcare (Basel, Switzerland) 2024; (12(5)) doi:10.3390/healthcare12050524.

Survival and causes of death in patients with alpha and beta-thalassemia in Northern Thailand.

Tantiworawit A, Kamolsripat T, Piriyakhuntorn P, et al.

Annals of medicine 2024; (56(1)):2338246 doi:10.1080/07853890.2024.2338246.

Impact of SCOPE Program on Health-Related Quality of Life and Health Status of Children With Thalassemia: A Quasi-Experimental Study.

K K, A P, Sikandar BJ

Journal of pediatric hematology/oncology nursing 2024; (41(3)):199-211 doi:10.1177/27527530231214542.

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia.

Locatelli F, Lang P, Wall D, et al.

The New England journal of medicine 2024; (390(18)):1663-1676 doi:10.1056/NEJMoa2309673.

Exploring the Clinical and Hematological Characteristics of Beta-Thalassemia Trait: A Comprehensive Analysis in a Tertiary Care Hospital Setting.

E Y, Vasudevan S, Sonti S, et al.

Cureus 2024; (16(5)):e61093 doi:10.7759/cureus.61093.

Prevalence and risk factors predisposing low bone mineral density in patients with thalassemia.

Ananvutisombat N, Tantiworawit A, Punnachet T, et al.

Frontiers in endocrinology 2024; (15()):1393865 doi:10.3389/fendo.2024.1393865.

Characterization and Clinical Assessment of a Peculiar Case of Hemolytic Anemia.

Castelgrande F, Viola G, Calabrese C, et al.

Journal of hematology 2024; (13(3)):108-115 doi:10.14740/jh1204.

Mutation Analysis of Exon 1 in the Hemoglobin Subunit Beta (HBB) Gene in Beta-Thalassemia.

Kumar KS, Patil MM, Bulagouda R, Kadakol GS

Cureus 2024; (16(7)):e65198 doi:10.7759/cureus.65198.

Hepatic Visualization on DXA Scan: An Ancilliary Finding.

Zubair A, Gill SM, Hassan A

JPMA. The Journal of the Pakistan Medical Association 2024; (74(9)):1721-1722 doi:10.47391/JPMA.24-73.

An Unexpected Detection of the Rare 48,XXYY in the Prenatal Diagnosis of a Fetus with β-Thalassemia Major.

Chen W, Ban S, Zhu Z, et al.

Clinical laboratory 2024; (70(10)) doi:10.7754/Clin.Lab.2024.240517.

Genetic Study for Identifying Beta Thalassemia Trait in Relatives of Children with Beta Thalassemia Major.

Elasheer OM, Radi SM, Khalaf MS, et al.

Cureus 2024; (16(9)):e70251 doi:10.7759/cureus.70251.

CRISPR-based gene therapy for the induction of fetal hemoglobin in sickle cell disease.

McManus M, Frangoul H, Steinberg MH

Expert review of hematology 2024; (17(12)):957-966 doi:10.1080/17474086.2024.2429605.

Long-term complications, survival and mortality in splenectomised adult transfusion-dependent thalassemia patients.

Bhattacharjee U, Khadwal A, Singh C, et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2025; (64(1)):104064 doi:10.1016/j.transci.2024.104064.

Hereditary disorders of ineffective erythropoiesis.

King RA, Khoriaty R

Blood cells, molecules & diseases 2025; (111()):102910 doi:10.1016/j.bcmd.2025.102910.

What is the importance of monitoring iron levels in different organs over time with magnetic resonance imaging in transfusion-dependent thalassemia patients?

Meloni A, Positano V, Ricchi P, et al.

Expert review of hematology 2025; (18(4)):291-299 doi:10.1080/17474086.2025.2486379.

Beta thalassemia syndromes: New insights.

Dordevic A, Mrakovcic-Sutic I, Pavlovic S, et al.

World journal of clinical cases 2025; (13(10)):100223 doi:10.12998/wjcc.v13.i10.100223.

Outcome of Haematopoietic Stem Cell Transplant in Beta-Thalassaemia Major: Single Centre Experience from a Low- and Middle-Income Country.

Khan H, Ghafoor T, Shahbaz N, et al.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2025; (35(4)):513-518 doi:10.29271/jcpsp.2025.04.513.

[Monitoring and interventions of growth disorders and endocrine function in children with transfusion-dependent thalassemia].

Fan X, Huang YY

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2025; (27(4)):389-394 doi:10.7499/j.issn.1008-8830.2501080.

Application of Fuzzy AHP for Medication Decision Making in Iron-Chelating Medications for Thalassemia.

Barzegari S, Rostamian H, Firoozi-Majd E, Arpaci I

Pharmacy (Basel, Switzerland) 2025; (13(3)) doi:10.3390/pharmacy13030086.

Beyond Simple Grinding: Methylammonium Chloride Promotes Sustainable, Cylinder-Free Mechanochemical Synthesis of Deferiprone.

Basoccu F, Piermarini S, Angelini T, et al.

ChemSusChem 2025; (18(16)):e202500457 doi:10.1002/cssc.202500457.

Iron Chelation Therapy.

Cappellini MD, Scaramellini N, Leoni S, Motta I

Advances in experimental medicine and biology 2025; (1480()):361-370 doi:10.1007/978-3-031-92033-2_23.

Study of Thyroid Function in Children With Beta-Thalassemia Major.

Kulkarni M, Kawade RV, S V

Cureus 2025; (17(6)):e86772 doi:10.7759/cureus.86772.

Efficacy of combination chelation with deferasirox and deferiprone in children with beta-thalassemia major: an audit from a unit in the developing world.

James V, Prakash A

Clinical and experimental medicine 2025; (25(1)):299 doi:10.1007/s10238-025-01687-y.

Magnitude of Beta-Hemoglobinopathies through Biomarkers among the Selected Tribes of Dharmapuri, Tamil Nadu: A Community-Based Cross-Sectional Study.

Angeline J K, Jennifer H G, C D A

International journal of hematology-oncology and stem cell research 2025; (19(2)):109-117 doi:10.18502/ijhoscr.v19i2.18548.

Clinical and hematological characteristics of beta-plus thalassemia and uncommon beta-chain hemoglobin variants in Northern Thailand.

Rukwong P, Natesirinilkul R, Sathitsamitphong L, et al.

Annals of medicine 2025; (57(1)):2551815 doi:10.1080/07853890.2025.2551815.

Novel Red Blood Cell Exchange Parameters for Treatment of Transfusion-Dependent Thalassemia Based on Experience of Five Patients.

Sevcik K, Jackson C, Williams SM, et al.

Journal of hematology 2025; (14(4)):210-213 doi:10.14740/jh2086.

Genetic Profiling and frequencies of Modifiers in Transfusion-Dependent Thalassemia.

Sohail G, Taj AS, Naz A, Khan MTM

Pakistan journal of medical sciences 2025; (41(9)):2600-2605 doi:10.12669/pjms.41.9.11571.

A Case Series on Beta Thalassemia Major With Secondary Diabetes Mellitus Due to Iron Overload and Other Complications.

Sahu UP, Rani N, Hasan O, et al.

Cureus 2025; (17(10)):e93915 doi:10.7759/cureus.93915.

Gene Therapies for Hemoglobinopathies: Efficacy, Cell Collection & Transfusion Support.

Inam Z, Han H, Webb J, Delaney M

Transfusion medicine reviews 2025; (39(4)):150930 doi:10.1016/j.tmrv.2025.150930.

Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy.

Duesberg MS, Schiller G

Cureus 2025; (17(10)):e95112 doi:10.7759/cureus.95112.

Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia.

Kwiatkowski JL, Thompson AA, Schneiderman J, et al.

Blood 2026; doi:10.1182/blood.2025029196.

miRNA-Mediated Regulation of γ-Globin to β-Globin Switching: Therapeutic Potential in β-Hemoglobinopathies.

Alotaibi D, Aldagdog F, Alramadhan S, et al.

International journal of molecular sciences 2026; (27(3)) doi:10.3390/ijms27031203.

Comparing two different doses of anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent thalassemia: an open-label, randomized clinical trial.

Huang Q, Liu R, Zheng B, et al.

Therapeutic advances in hematology 2026; (17()):20406207261416816 doi:10.1177/20406207261416816.

Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.

Testa U, Castelli G, Pelosi E

Journal of clinical medicine 2026; (15(4)) doi:10.3390/jcm15041379.

Current Status of Clinical Gene Therapy for Hemophilia and Globin Disorders.

Winkler R, Herath I, Kaczmarek R, et al.

Journal of blood medicine 2026; (17()):576017 doi:10.2147/JBM.S576017.